Lab experiments found that combining CBD and THC at a 3:1 ratio was more effective at killing ovarian cancer cells than either cannabinoid alone, working through apoptosis and autophagy pathways.
Oncology researchers, cannabinoid scientists, and patients interested in cannabis and cancer research.
What the researchers found
CBD:THC at a 3:1 ratio showed synergistic cytotoxicity against ovarian cancer cell lines. The combination induced apoptosis (programmed cell death) and autophagy at lower concentrations than either compound alone. CBD alone was more cytotoxic than THC alone. The combination also reduced cell migration.
Why it matters
Ovarian cancer has limited treatment options and high mortality. The synergistic effect of CBD:THC combinations suggests cannabinoids could be explored as adjunct therapies, potentially allowing lower doses of each compound.
The numbers in context
Optimal ratio: 3:1 CBD:THC. Synergistic cytotoxicity confirmed. Apoptosis and autophagy both activated. Cell migration reduced.
How the study worked
In vitro study testing CBD, THC, and combinations at various ratios against multiple ovarian cancer cell lines. MTT viability assays, flow cytometry for apoptosis, western blot for autophagy markers, and wound healing assays for migration.
What this study cannot tell us
In vitro only — cancer cells in a dish may not reflect tumor behavior in the body. Specific cell lines may not represent all ovarian cancers. Bioavailability and achievable tissue concentrations not addressed.
How to read the evidence
Well-designed in vitro study with multiple assays confirming mechanism, but lab-only results have a long road to clinical relevance.
When this study was published
2025 preclinical study on cannabinoid combinations against ovarian cancer cells.
The bigger picture
The "entourage effect" — cannabinoids working better together — is often discussed anecdotally. This study provides mechanistic evidence for synergy in a specific cancer model, supporting the rationale for combination cannabinoid therapies in oncology research.
Questions still open
- Would CBD:THC combinations show similar synergy in animal ovarian cancer models?
- Could this ratio inform clinical trial design for cannabinoid adjunct therapy?
Common questions
Can CBD and THC kill cancer cells?
Is combining CBD and THC better for cancer?
Read the original research
Selective anti-cancer effects of cannabidiol and Δ9-tetrahydrocannabinol via PI3K/AKT/mTOR inhibition and PTEN restoration in ovarian cancer cells.
Frontiers in pharmacology, 16, 1693129
Citation
Tong, Siyao; Loilome, Watcharin; Namwat, Nisana; Klanrit, Poramate; Wangwiwatsin, Arporn; Win, Zar Zar; Koyabuth, Preeya; Chumworathayi, Bandit. (2025). Selective anti-cancer effects of cannabidiol and Δ9-tetrahydrocannabinol via PI3K/AKT/mTOR inhibition and PTEN restoration in ovarian cancer cells.. Frontiers in pharmacology, 16, 1693129. https://doi.org/10.3389/fphar.2025.1693129
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk